钠-葡萄糖协同转运蛋白2抑制剂对合并糖尿病的非酒精性脂肪性肝病的影响：基于系列肝活检的初步前瞻性研究
Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies.
作者信息
Akuta Norio, Watanabe Chizuru, Kawamura Yusuke, Arase Yasuji, Saitoh Satoshi, Fujiyama Shunichiro, Sezaki Hitomi, Hosaka Tetsuya, Kobayashi Masahiro, Kobayashi Mariko, Suzuki Yoshiyuki, Suzuki Fumitaka, Ikeda Kenji, Kumada Hiromitsu
机构信息
Department of Hepatology Toranomon Hospital and Okinaka Memorial Institute for Medical Research Tokyo Japan.
Department of Endocrinology and Metabolism, Toranomon Hospital Tokyo Japan.
出版信息
Hepatol Commun. 2017 Feb 27;1(1):46-52. doi: 10.1002/hep4.1019. eCollection 2017 Feb.
A prospective study based on serial liver biopsies was performed to investigate the efficacy of sodium-glucose cotransporter 2 inhibitor for nonalcoholic fatty liver disease complicated with type 2 diabetes mellitus. : Treatment for 24 weeks resulted in improvement in histopathologic features in all 5 patients. (Hepatology Communications 2017;1:46-52).
进行了一项基于系列肝活检的前瞻性研究，以调查钠-葡萄糖协同转运蛋白2抑制剂对合并2型糖尿病的非酒精性脂肪性肝病的疗效。：24周的治疗使所有5例患者的组织病理学特征得到改善。（《肝脏病学通讯》2017年；1：46 - 52）
Zotero 插件